COVID-19 Vaccine’s mRNA Technology Adapted for First Antibiotic-Resistant Bacteria Vaccine
Researchers from Tel Aviv University have developed the first mRNA-based vaccine targeting the antibiotic-resistant bacterium Yersinia pestis, known for causing the bubonic plague. This innovative vaccine employs a method similar…
